Skip to main content
Clinical Trials/NCT02786654
NCT02786654
Completed
N/A

β Blocker Use and Mortality in Hospital Survivors of Acute Myocardial Infarction Without Heart Failure

University of Leeds1 site in 1 country179,810 target enrollmentJanuary 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Acute Myocardial Infarction
Sponsor
University of Leeds
Enrollment
179810
Locations
1
Primary Endpoint
All cause mortality
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The aim of the study is to investigate the association between the use of β blockers and mortality among hospital survivors of acute myocardial infarction without heart failure.

Registry
clinicaltrials.gov
Start Date
January 2007
End Date
June 2013
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tatendashe Bernadette Dondo

Research assistant

University of Leeds

Eligibility Criteria

Inclusion Criteria

  • acute myocardial infarction patients only
  • aged 18 to 100 years

Exclusion Criteria

  • other final diagnosis besides acute myocardial infarction
  • died in-hospital
  • patients with missing mortality data
  • aged \> 100
  • patients with previous acute myocardial infarction or angina
  • patients who have received coronary interventions before
  • patients with heart failure
  • patients with β blocker prior use
  • patients contraindicated for β blocker use
  • patients with use of a loop diuretic

Outcomes

Primary Outcomes

All cause mortality

Time Frame: 1 year

Secondary Outcomes

  • All cause mortality(30 days)

Study Sites (1)

Loading locations...

Similar Trials